Alpha Crest Capital Management LLC Lantheus Holdings, Inc. Transaction History

Alpha Crest Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$61.42 - $86.29 $175,354 - $246,357	-2,855 Reduced 17.71%	13,270 $933,000
Q2 2022 Aug 11, 2022	SELL	$55.54 - $72.65 $276,144 - $361,215	-4,972 Reduced 23.57%	16,125 $1.07 Million
Q1 2022 May 12, 2022	SELL	$24.28 - $56.64 $401,275 - $936,089	-16,527 Reduced 43.93%	21,097 $1.17 Million
Q4 2021 Feb 09, 2022	BUY	$22.54 - $30.44 $848,044 - $1.15 Million	37,624 New	37,624 $1.09 Million
Q2 2021 Aug 12, 2021	SELL	$19.51 - $27.64 $339,474 - $480,936	-17,400 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$13.77 - $21.66 $11,016 - $17,328	800 Added 4.82%	17,400 $372,000
Q4 2020 Feb 12, 2021	BUY	$10.75 - $14.91 $36,550 - $50,694	3,400 Added 25.76%	16,600 $224,000
Q3 2020 Nov 12, 2020	BUY	$11.98 - $16.34 $158,136 - $215,688	13,200 New	13,200 $167,000
Q2 2020 Aug 12, 2020	SELL	$10.34 - $15.51 $529,408 - $794,112	-51,200 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$9.11 - $20.05 $466,432 - $1.03 Million	51,200 New	51,200 $653,000

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.13B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.